Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILs
Oncoimmunology
.
2014 Jan 3:3:e27580.
doi: 10.4161/onci.27580.
eCollection 2014.
Authors
Leah Alabanza
1
,
Sacha Gnjatic
1
,
Nina Bhardwaj
1
,
Joshua Brody
1
Affiliation
1
Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai.
PMID:
25339995
PMCID:
PMC4203490
DOI:
10.4161/onci.27580
No abstract available